Overview
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 1998-03-01. Active
20 1880 0009 0000 0011 0252 6001- 47 1880 0009 0000 0011 0252 6000
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 468.9KPLN 468,869 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 17, 2011 | Commercial Companies Code notice | |
| Nov 3, 2010 | Merger plan |
Public aid
No public aid cases recorded in the last 10 years.
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-02-24 | Procurement of rapid antigene tests for diagnostic of covid-19 | $6.1M$6,136,076 | 2.2.26 - Instrument for emergency support within the Union (ESI) |
Tenders
162 tenders recorded as contractor: 58 national ($6,875,437) and 104 EU ($100,999,619), and 1 as contracting authority.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 7, 2026 | Dostawa odczynników i materiałów laboratoryjnych wraz z dzierżawą analizatorów | –– | Miejski Szpital Zespolony w Olsztynie | |
| Sep 28, 2026 | Dostawa odczynników i sprzętu laboratoryjnego II | –– | Zespół Opieki Zdrowotnej w Oławie | |
| Sep 24, 2026 | Dostawa odczynników do wykonywania badań immunochemicznych, biochemicznych wraz z dzierżawą analizatora | –– | Samodzielny Publiczny Zakład Opieki Zdrowotnej w Lubaczowie |
Public sector contracts
Abbott Laboratories Poland is the contractor in 51 public sector contracts, worth PLN 116.51m in total. They were signed with 33 public buyers. The largest number (2) were signed with Uniwersytecki Szpital Kliniczny w Poznaniu.
| Public buyer | Value | |
|---|---|---|
| Samodzielny Publiczny Szpital Kliniczny Im.Andrzeja Mielęckiego Śląskiego Uniwersytetu Medycznego w Katowicach | PLN 22,140 | |
| Samodzielny Publiczny Szpital Kliniczny Im.Andrzeja Mielęckiego Śląskiego Uniwersytetu Medycznego w Katowicach | PLN 2,525,874 | |
| Uniwersytecki Szpital Kliniczny w Poznaniu | PLN 6,773 | |
| Samodzielny Zespół Publicznych Zakładów Lecznictwa Otwartego Warszawa Bemowo-Włochy | PLN 2,373 | |
| Samodzielny Publiczny Zakład Opieki Zdrowotnej Szpital Uniwersytecki w Krakowie | PLN 1,202,720 |
Public procurement disputes (KIO)
Abbott Laboratories Poland has been a party to 101 cases before the National Appeal Chamber (since 2008). It filed 62 appeals (16 upheld, 29 dismissed, 14 discontinued, 1 rejected). In 39 cases it joined the proceedings as a participant.
Trademarks
Abbott Laboratories Poland currently holds no active trademarks with the Polish Patent Office. 5 marks have expired or were not registered. The first mark was filed in 2004.
| Mark | Protected until | |
|---|---|---|
| DISNEMAR XYLO(word) | – | |
| Optium Omega | – | |
| GlukoLink | – | |
| MediSense. Możesz na nas liczyć.(word) | – | |
| Mark without a word element(figurative) | – |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
Each of the members of the management board acting independently is authorized to represent the company, make declarations and sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 221,728 | $5,989,411.13 | 31.609% | |
St. Jude Medical Luxembourg | 479,744 | $12,959,049.16 | 68.391% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Pfizer Trading Polskasp. z o.o. | $299,067,553.99 | pfizer.pl | ||
| Berlin-Chemie / Menarini Polskasp. z o.o. | $240,194,615.27 | berlin-chemie.pl | ||
| Bristol-Myers Squibb Polskasp. z o.o. | $230,722,737.87 | bms.com | ||
| Takeda Pharmasp. z o.o. | $246,400,594.27 | takeda.com | ||
| Natur Produkt Zdrovitsp. z o.o. | $205,379,396.79 | zdrovit.pl | ||
| Astellas Pharmasp. z o.o. | $220,199,081.58 | astellas.com | ||
| Bialmedsp. z o.o. | $203,238,055.12 | bialmed.pl | ||
| Roche Diagnostics Polskasp. z o.o. | $199,208,461.57 | roche.pl | ||
| Servier Polska Servicessp. z o.o. | $157,143,144.15 | servier.pl | ||
| Angelini Pharma Polskasp. z o.o. | $119,629,315.69 | angelinipharma.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-11-06 | Share capital change (22,172,800.00 PLN → 70,147,200.00 PLN) | |
| 2019-01-02 | Share capital change (29,500,300.00 PLN → 22,172,800.00 PLN) | |
| 2015-02-02 | Share capital change (34,877,900.00 PLN → 29,500,300.00 PLN) | |
| 2010-12-31 | Share capital change (30,084,800.00 PLN → 34,877,900.00 PLN) | |
| 2009-12-04 | Address change (Postępu 18a, 02-676, Warszawa → Postępu 21b, 02-676, Warszawa) |
FAQ
Last updated: 2026-08-07